The Role of IL-33/ST2 in COPD and Its Future as an Antibody Therapy

COPD is a leading cause of mortality and morbidity worldwide and is associated with a high socioeconomic burden. Current treatment includes the use of inhaled corticosteroids and bronchodilators, which can help to improve symptoms and reduce exacerbations; however, there is no solution for restoring...

Descripción completa

Detalles Bibliográficos
Autores principales: Riera-Martínez, Lluc, Cànaves-Gómez, Laura, Iglesias, Amanda, Martin-Medina, Aina, Cosío, Borja G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217986/
https://www.ncbi.nlm.nih.gov/pubmed/37240045
http://dx.doi.org/10.3390/ijms24108702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217986/
https://www.ncbi.nlm.nih.gov/pubmed/37240045
http://dx.doi.org/10.3390/ijms24108702

Ejemplares similares